- Investing Ideas
- U.S. Pharmaceuticals & Biotech Breakout Stocks
U.S. Pharmaceuticals & Biotech Breakout Stocks
Results
12
Stocks where the price continues to rise after more than a year of consistent gains.
12 companies
Corcept Therapeutics
Market Cap: US$10.0b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$118.32
7D
22.4%
1Y
76.2%
Avantor
Market Cap: US$9.7b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$13.86
7D
22.1%
1Y
3.1%
Kiniksa Pharmaceuticals International
Market Cap: US$6.3b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$78.20
7D
24.0%
1Y
158.4%
Forte Biosciences
Market Cap: US$1.9b
Operates as a clinical-stage biopharmaceutical company in the United States.
FBRX
US$76.98
7D
28.9%
1Y
671.3%
Bausch Health Companies
Market Cap: US$1.7b
Operates as a diversified specialty pharmaceutical and medical device company.
BHC
US$6.03
7D
35.5%
1Y
2.4%
Agenus
Market Cap: US$296.7m
A clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.
AGEN
US$7.91
7D
27.8%
1Y
43.3%
Anika Therapeutics
Market Cap: US$215.2m
A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.
ANIK
US$18.02
7D
22.8%
1Y
118.3%
Entera Bio
Market Cap: US$147.9m
A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.
ENTX
US$2.95
7D
38.5%
1Y
52.8%
Panacea Life Sciences Holdings
Market Cap: US$5.4m
Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.
PLSH
US$0.092
7D
23.2%
1Y
185.1%
Maple Leaf Green World
Market Cap: US$1.2m
Does not have significant operations.
MGWF.F
US$0.032
7D
112.5%
1Y
174.3%
Affymax
Market Cap: US$74.5k
Does not have significant operations.
AFFY
US$0.0015
7D
50.0%
1Y
87.5%
ObsEva
Market Cap: US$11.7k
A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.
OBSE.F
US$0.0001
7D
9,900.0%
1Y
900.0%